# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-308672
Filing Date
2021-10-27
Accepted
2021-10-27 07:13:09
Documents
89
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d223700d10q.htm iXBRL | 10-Q | 3349859
2 | EX-31.1 | d223700dex311.htm | EX-31.1 | 10684
3 | EX-31.2 | d223700dex312.htm | EX-31.2 | 10669
4 | EX-32 | d223700dex32.htm | EX-32 | 4314
| Complete submission text file | 0001193125-21-308672.txt |  | 12832629

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20210930.xsd | EX-101.SCH | 77245
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20210930_cal.xml | EX-101.CAL | 47324
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20210930_def.xml | EX-101.DEF | 513086
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20210930_lab.xml | EX-101.LAB | 537868
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20210930_pre.xml | EX-101.PRE | 548609
10 | EXTRACTED XBRL INSTANCE DOCUMENT | d223700d10q_htm.xml | XML | 2799913

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 211350679
SIC: 2834 Pharmaceutical Preparations